|Immunogen||Synthetic peptide corresponding to amino acids 18 to 31 of human ACE2 (Genbank accession NP_068576)|
|Target/Specificity||Reacts with Human Angiotensin Converting Enzyme 2 (ACE2, SARS Receptor) N-terminal, amino acids 1831. Does not cross react with ACE1.|
|Preservative||0.02% Sodium azide|
|Format||Affinity Purified, Liquid|
|Storage||Store (up to one year) at 2-8°C.|
|Precautions||Rabbit Antibody to Human angiotensin Converting Enzyme 2 (aCE2) (SaRS Receptor), N-terminal is for research use only and not for use in diagnostic or therapeutic procedures.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The references listed below are for research purposes only.1. Donoghue, M., et al., (2000), “A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9”, Circ. Res., 87, 1-92. Tipnis, S.R., et al., (2000), “A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase”, J. Biol. Chem., 275, 33238-33243.3. Li, W., et al., (2003), “Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus”, Nature, 426, 450-454.4. Crackower, M.A., et al., (2002), “Angiotensin-converting enzyme 2 is an essential regulator of heart function” Nature, 4f7, 822-828.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.